electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M

electroCore, Inc.

2025-Q3 EPS reported -$1.31 revenue$22,789,000

Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.
Net loss $3.4M ($0.40 per share) vs $2.5M loss in Q3 2024; adjusted EBITDA net loss $2.0M vs $2.1M.
FY2025 revenue guidance raised to $31.5-$32.5M; expects first quarter of positive adjusted EBITDA in H2 2026.
Total cash $13.2M at Sep 30, 2025, up from $12.2M at Dec 31, 2024.
Prescription devices sales $6.81M (+19% YoY); health & wellness $1.88M (+121% YoY).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.